European public assessment reports

  • Email
  • Help

This page allows you to find the European public assessment reports (EPAR) for human medicines published by the European Medicines Agency (EMA).

The EMA publishes an EPAR for every medicine granted a central marketing authorisation by the European Commission following an assessment by the EMA's Committee for Medicinal Products for Human Use (CHMP). EPARs are full scientific assessment reports of medicines authorised at a European Union level. 

Use this search to find information including a public-friendly summary in question-and-answer format and the package leaflet. You can also find information on medicines that have been refused a marketing authorisation or that have been suspended or withdrawn after being approved.

As of October 2016, EMA publishes the clinical data submitted by pharmaceutical companies to support their marketing applications for human medicines under the centralised procedure, allowing the public to better understand the Agency’s decision-making. For more information see clinical data publication.

The Agency does not evaluate all medicines currently in use in Europe. If you cannot find the medicine you need through this search, please visit the website of your national health authority.

More information is available on the Central authorisation procedure and in EPARs: background and context.

Document status

Include:

Browse by letter

Browse by letter for medicines that have a European Public Assessment Report:

Or for other types of content pick from the navigation on the left.

Search by keyword

Search for keyword:

Search by therapeutic area

Browse the database based on therapeutic area:

/

Browse by type

Browse by type:

Download results to spreadsheet
EPAR Search results
Name Active substance Therapeutic area Date of authorisation / refusal Additional monitoring Orphan     Has current safety alert Status
Abseamed

epoetin alfa

Anemia Cancer Kidney Failure, Chronic 2007-08-28           Authorised
Binocrit

epoetin alfa

Anemia Kidney Failure, Chronic 2007-08-28           Authorised
Bortezomib Accord

bortezomib

Multiple Myeloma 2015-07-20           Authorised
Bortezomib Hospira

bortezomib

Multiple Myeloma 2016-07-22           Authorised
Bortezomib Sun

bortezomib

Multiple Myeloma 2016-07-22           Authorised
Caelyx

doxorubicin hydrochloride

Breast Neoplasms Multiple Myeloma Ovarian Neoplasms Sarcoma, Kaposi 1996-06-21           Authorised
Darzalex

daratumumab

Multiple Myeloma 2016-05-20           Authorised
Empliciti

elotuzumab

Multiple Myeloma 2016-05-11           Authorised
Epoetin Alfa Hexal

epoetin alfa

Anemia Cancer Kidney Failure, Chronic 2007-08-28           Authorised
Farydak

panobinostat lactate anhydrous

Multiple Myeloma 2015-08-28           Authorised
Flebogamma DIF (previously Flebogammadif)

human normal immunoglobulin

Bone Marrow Transplantation Guillain-Barre Syndrome Immunologic Deficiency Syndromes Mucocutaneous Lymph Node Syndrome Purpura, Thrombocytopenic, Idiopathic 2007-07-23           Authorised
Hizentra

human normal immunoglobulin (SCIg)

Immunologic Deficiency Syndromes 2011-04-14           Authorised
HyQvia

human normal immunoglobulin

Immunologic Deficiency Syndromes 2013-05-16           Authorised
Imnovid (previously Pomalidomide Celgene)

pomalidomide

Multiple Myeloma 2013-08-05           Authorised
IntronA

interferon alfa-2b

Carcinoid Tumor Hepatitis B, Chronic Hepatitis C, Chronic Leukemia, Hairy Cell Leukemia, Myelogenous, Chronic, BCR-ABL Positive Lymphoma, Follicular Melanoma Multiple Myeloma 2000-03-09           Authorised
Kiovig

human normal immunoglobulin (IVIg)

Bone Marrow Transplantation Guillain-Barre Syndrome Immunologic Deficiency Syndromes Mucocutaneous Lymph Node Syndrome Purpura, Thrombocytopenic, Idiopathic 2006-01-19           Authorised
Kyprolis

carfilzomib

Multiple Myeloma 2015-11-19           Authorised
Mozobil

plerixafor

Hematopoietic Stem Cell Transplantation Lymphoma Multiple Myeloma 2009-07-31           Authorised
Neofordex

dexamethasone

Multiple Myeloma 2016-03-16           Authorised
Ninlaro

ixazomib citrate

Multiple Myeloma 2016-11-21           Authorised
Privigen

human normal immunoglobulin (IVIg)

Bone Marrow Transplantation Guillain-Barre Syndrome Immunologic Deficiency Syndromes Mucocutaneous Lymph Node Syndrome Purpura, Thrombocytopenic, Idiopathic 2008-04-25           Authorised
Retacrit

epoetin zeta

Anemia Blood Transfusion, Autologous Cancer Kidney Failure, Chronic 2007-12-18           Authorised
Revlimid

lenalidomide

Multiple Myeloma 2007-06-14           Authorised
Silapo

epoetin zeta

Anemia Blood Transfusion, Autologous Cancer Kidney Failure, Chronic 2007-12-18           Authorised
Thalidomide Celgene (previously Thalidomide Pharmion)

thalidomide

Multiple Myeloma 2008-04-16           Authorised